Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.

被引：0
|
作者：
Sanford, Nina Niu
Xu, Xiaohan
Sher, David J.
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] UT Southwestern, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.357
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
357
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ADJUVANT TREATMENT AND SURVIVAL IN PATIENTS WITH STAGE II/III SMALL BOWEL ADENOCARCINOMA.
    Li, B.
    Brown, E. C.
    Egawa, F.
    Lambrecht, J.
    Krishnamurty, D. M.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [22] Randomized phase III trial of FOLFOX versus XELOX as adjuvant chemotherapy in patients with early-stage colorectal adenocarcinoma.
    Pectasides, Dimitrios G.
    Papaxoinis, George
    Xanthakis, Ioannis
    Kouvatseas, George
    Kotoula, Vassiliki
    Xiros, Nikolaos
    Samantas, Epaminondas
    Papakostas, Pavlos
    Klouvas, George
    Varthalitis, Ioannis I.
    Pentheroudakis, George E.
    Fountzilas, George
    Bafaloukos, Dimitris
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Racial disparities in outcomes of patients with stage I-III triple-negative breast cancer after adjuvant chemotherapy: a post-hoc analysis of the E5103 randomized trial
    Leonard, Saskia
    Jones, Alyssa N.
    Newman, Lisa
    Chavez-MacGregor, Mariana
    Freedman, Rachel A.
    Mayer, Erica L.
    Mittendorf, Elizabeth A.
    King, Tari A.
    Kantor, Olga
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (01) : 185 - 193
  • [24] Is surgery (gastrectomy) alone more effective than surgery combined with adjuvant chemotherapy for the treatment of Stage I-III gastric adenocarcinoma?
    Rikhraj, Naveena Kaur
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [25] Prognostic Impact of CA19-9 Level at Diagnosis in Resected Stage I-III Pancreatic Adenocarcinoma: a US Population Study
    Mirkin, K.
    Hollenbeak, C.
    Wong, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 14 - 15
  • [26] Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma
    Omar Abdel-Rahman
    Jennifer Spratlin
    Sheryl Koski
    Medical Oncology, 2021, 38
  • [27] Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma
    Abdel-Rahman, Omar
    Spratlin, Jennifer
    Koski, Sheryl
    MEDICAL ONCOLOGY, 2021, 38 (02)
  • [28] Effect of surgical resection on survival following neoadjuvant chemotherapy in patients with stage I-II pancreatic adenocarcinoma.
    Henrix, Ryan James
    Rouanet, Eva
    Schultz, Kurt
    Ali, Tasneem
    Switzer, Bradley Alan
    Bathini, Venu Gopal
    Whalen, Giles Francis
    Lafemina, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [29] ROS1 fusions in resected stage I-III adenocarcinoma (ADC): A Lungscape ETOP study
    Speel, E-J. M.
    Radonic, T.
    Dafni, U.
    Thunnissen, E.
    Ruschoff, J. H.
    Kowalski, J.
    Kerr, K. M.
    Bubendorf, L.
    Valero, I. Sansano
    Joseph, L.
    Navarro, A.
    Monkhorst, K.
    Madsen, L. B.
    Losa, J. Hernandez
    Biernat, W.
    Dellaporta, T.
    Kammler, R.
    Peters, S.
    Stahel, R. A.
    Finn, S. P.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S144 - S145
  • [30] IS ADJUVANT CHEMOTHERAPY BENEFICIAL IN ELDERLY PATIENTS WITH STAGE III APPENDICEAL ADENOCARCINOMA?
    Pu, Tracey
    Ghabra, Shadin
    Swinarska, Joanna T.
    Akmal, Sarfraz R.
    Nguyen, Lily L.
    Tran, Thuy B.
    Blakely, Andrew M.
    Eng, Oliver S.
    GASTROENTEROLOGY, 2023, 164 (06) : S1476 - S1476
12345